Maturation and diversity of the VRC01-antibody lineage over 15 years of chronic HIV-1 infection X Wu, Z Zhang, CA Schramm, MG Joyce, Y Do Kwon, T Zhou, Z Sheng, ... Cell 161 (3), 470-485, 2015 | 259 | 2015 |
Anti–transforming growth factor β receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells Z Zhong, KD Carroll, D Policarpio, C Osborn, M Gregory, R Bassi, ... Clinical Cancer Research 16 (4), 1191-1205, 2010 | 133 | 2010 |
Unveiling the crucial intermediates in androgen production PJ Mak, MC Gregory, IG Denisov, SG Sligar, JR Kincaid Proceedings of the National Academy of Sciences 112 (52), 15856-15861, 2015 | 77 | 2015 |
Nanodiscs: a controlled bilayer surface for the study of membrane proteins MA McLean, MC Gregory, SG Sligar Annual review of biophysics 47, 107-124, 2018 | 76 | 2018 |
A neutralizing antibody recognizing primarily N-linked glycan targets the silent face of the HIV envelope T Zhou, A Zheng, U Baxa, GY Chuang, IS Georgiev, R Kong, S O’Dell, ... Immunity 48 (3), 500-513. e6, 2018 | 76 | 2018 |
Differential hydrogen bonding in human CYP17 dictates hydroxylation versus lyase chemistry M Gregory, PJ Mak, SG Sligar, JR Kincaid Angewandte Chemie (International ed. in English) 52 (20), 5342, 2013 | 75 | 2013 |
Kinetic solvent isotope effect in human P450 CYP17A1-mediated androgen formation: evidence for a reactive peroxoanion intermediate MC Gregory, IG Denisov, YV Grinkova, Y Khatri, SG Sligar Journal of the American Chemical Society 135 (44), 16245-16247, 2013 | 74 | 2013 |
Nanodiscs in the studies of membrane-bound cytochrome P450 enzymes A Luthra, M Gregory, YV Grinkova, IG Denisov, SG Sligar Cytochrome P450 Protocols, 115-127, 2013 | 66 | 2013 |
Active site proton delivery and the lyase activity of human CYP17A1 Y Khatri, MC Gregory, YV Grinkova, IG Denisov, SG Sligar Biochemical and biophysical research communications 443 (1), 179-184, 2014 | 65 | 2014 |
Interaction of KRas4b with anionic membranes: A special role for PIP2 MC Gregory, MA McLean, SG Sligar Biochemical and biophysical research communications 487 (2), 351-355, 2017 | 52 | 2017 |
Evidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen synthesis R Duggal, Y Liu, MC Gregory, IG Denisov, JR Kincaid, SG Sligar Biochemical and biophysical research communications 477 (2), 202-208, 2016 | 42 | 2016 |
Human cytochrome CYP17A1: The structural basis for compromised lyase activity with 17-hydroxyprogesterone PJ Mak, R Duggal, IG Denisov, MC Gregory, SG Sligar, JR Kincaid Journal of the American Chemical Society 140 (23), 7324-7331, 2018 | 39 | 2018 |
Influence of transmembrane helix mutations on cytochrome P450-membrane interactions and function G Mustafa, PP Nandekar, TJ Camp, NJ Bruce, MC Gregory, SG Sligar, ... Biophysical journal 116 (3), 419-432, 2019 | 32 | 2019 |
Resonance Raman spectroscopy reveals that substrate structure selectively impacts the heme-bound diatomic ligands of CYP17 PJ Mak, MC Gregory, SG Sligar, JR Kincaid Biochemistry 53 (1), 90-100, 2014 | 26 | 2014 |
Studies of : Gamma Rays, Lifetimes, and Mössbauer Effect MC Gregory, BL Robinson, S Jha Physical Review 180 (4), 1158, 1969 | 16 | 1969 |
Human P450 CYP17A1: control of substrate preference by asparagine 202 MC Gregory, PJ Mak, Y Khatri, JR Kincaid, SG Sligar Biochemistry 57 (5), 764-771, 2018 | 9 | 2018 |
Importance of Asparagine 202 in manipulating active site structure and substrate preference for human CYP17A1 Y Liu, I Denisov, M Gregory, SG Sligar, JR Kincaid Biochemistry 61 (7), 583-594, 2022 | 4 | 2022 |
Mechanism of the clinically relevant E305G mutation in human P450 CYP17A1 Y Liu, Y Grinkova, MC Gregory, IG Denisov, JR Kincaid, SG Sligar Biochemistry 60 (43), 3262-3271, 2021 | 4 | 2021 |
The Mössbauer effect in 191Ir and 189Os S Jha, WR Owens, MC Gregory, BL Robinson Physics Letters B 25 (2), 115-117, 1967 | 4 | 1967 |
Understanding the mechanism of androgen biosynthesis MC Gregory University of Illinois at Urbana-Champaign, 2016 | 1 | 2016 |